This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.
The international journal of neuropsychopharmacology, 23(9), 581-586
Citation
Alvarez, X Anton; Alvarez, Irene; Martinez, Antia; Romero, Iria; Benito, Concha; Suarez, Irene; Mourente, Silvia; Fantini, Manuel; Figueroa, Jesús; Aleixandre, Manuel; Linares, Carlos; Muresanu, Dafin; Winter, Stefan; Moessler, Herbert. (2020). Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer's Disease.. The international journal of neuropsychopharmacology, 23(9), 581-586. https://doi.org/10.1093/ijnp/pyaa046